mbnu FY2016 Annual Report 5.2

mbnu FY2016 Annual Report 5.2

Figure: (I) Schematic of the syringe-based device. (II) Immunoassay performed within a microfluidic device (a) patterned with green fluorescent antibody to capture (b) complimentary red fluorescent antibody. (c) Depicts overlayed images of (a) and (b).

Date:
13 March 2024
Share on: